Skip to main content
Premium Trial:

Request an Annual Quote

Idaho Technology Licenses PCR Technology to DuPont

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Idaho Technology said today it has a signed a licensing agreement with E.I du Pont de Nemours, more commonly known as DuPont, covering reagents and methods using Idaho Tech's Sybr Green I technology and post-PCR melting curve analysis.

The deal was reached through DuPont's Qualicon Business.

Terms of the agreement were not disclosed.

In a statement, Idaho Tech said that it extends the company's ongoing program to license "its broad and valuable intellectual property portfolio in cooperation with Roche Diagnostics." Idaho Tech licensed the rapid PCR technology from the University of Utah. It developed the LightCycler PCR-based platform and sublicensed it to Roche.

The agreement announced today took effect on June 18.

Since the start of 2009, the company has reached other licensing deals covering its PCR technology with Life Technologies Applied Biosystems business, Qiagen, Thermo Fisher Scientific, and Finnzymes, now part of Thermo Fisher.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.